Fallowfield2022_Article_IMPARTERPhase1OfAnIntervention.pdf (627.2 kB)
IMPARTER, Phase 1 of an intervention to improve patients’ understanding of gene expression profiling tests in breast cancer
Version 2 2023-06-12, 08:13
Version 1 2023-06-10, 01:58
journal contribution
posted on 2023-06-12, 08:13 authored by Lesley FallowfieldLesley Fallowfield, D Farewell, H Jones, Shirley May, Susan Catt, Rachel StarkingsRachel Starkings, Valerie JenkinsValerie JenkinsPurpose To compare participants’ knowledge about gene expression profiling (GEP) tests and recurrence risks after reading an information leaflet with that following viewing of an information film. Methods Using a randomised cross-over design, at time-point one (T1), women aged 45–75 years without breast cancer either read leaflets or watched information films about Oncotype DX or Prosigna tests. Participants answered nine questions assessing knowledge (maximum score 18). Next-day information in the opposite modality was provided and knowledge re-assessed. Additional questions probed which format was easiest to understand, participants’ preferences for film or leaflet and their reasons for these. Results 120 women participated (60 received OncotypeDX films and leaflets; 60 received the Prosigna versions). T1 mean knowledge scores were higher following film viewing (13.37) compared with that after reading leaflets (9.25) (mean difference 4.1; p?
Funding
IMproving PAtient undeRstanding of GEP TEst Results (IMPARTER): development and testing of a patient information film; G2493; BREAST CANCER RESEARCH FOUNDATION
History
Publication status
- Published
File Version
- Published version
Journal
Breast Cancer Research and TreatmentISSN
0167-6806Publisher
SpringerExternal DOI
Department affiliated with
- Sussex Health Outcomes Research & Education in Cancer (SHORE-C) Publications
Research groups affiliated with
- Sussex Health Outcomes Research and Education in Cancer Publications
Full text available
- Yes
Peer reviewed?
- Yes
Legacy Posted Date
2021-12-07First Open Access (FOA) Date
2022-01-10First Compliant Deposit (FCD) Date
2021-12-06Usage metrics
Categories
No categories selectedLicence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC